Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
Clinical trial NCT00490568 · TERMINATED
Trial details
- NCT number
- NCT00490568
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-08
- Primary completion
- 2009-06-01
- Enrollment
- 1461
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.